JANSSEN'S RISPERDAL PATENT UPHELD

Janssen said Monday a U.S. District Court upheld a Risperdal patent, blocking Mylan and Dr. Reddy from launching their generics until 2007.

UPI (http://www.upi.com/HealthBusiness/view.php?StoryID=20061016-093431-5197r)